There are at least three distinct MAP kinase signaling modules in mammalian cells, distinguished by the family of kinases (Erk, SAPK/JNK, or p38) that is ultimately activated. Many input signals activate multiple MAP kinase cascades, and the mechanisms that control the speci®city of signal output are not well understood. We show that SEK1/MKK4, a MAP kinase kinase proposed to activate SAPK/JNK, is a very potent inhibitor of p54 SAPKb/JNK3 both in vitro and in vivo if present at equimolar or higher ratios. In contrast SEK can activate SAPK when present in substoichiometric amounts, but this activation is slow, consistent with the rate-limiting step in activation being the dissociation of an inactive SEK : SAPK complex. The N-terminal unique region of SEK is both necessary and partially sucient for inhibition of SAPK, and is also necessary for activation of SAPK by SEK in vitro. We have also used the p38 MAP kinase and its activator MKK6 to examine the regulatory relationships among dierent kinases involved in stress responses. We show using puri®ed kinases that inhibitory activity is speci®c for the combination of SEK and SAPK: SEK can activate but not inhibit p38, and MKK6 can activate but not inhibit SAPKb and p38. These results reveal a potential mechanism for regulating stress-activated kinases, adding to a growing body of evidence suggesting that MAP kinases are controlled by relatively stable interactions with their activators.
Introduction
All eukaryotes possess conserved protein kinase cascades that result in the activation of what were originally termed Mitogen Activated Protein kinases (MAP kinases or MAPKs) (reviewed in Lewis et al., 1998; Paul et al., 1997; Waskiewicz and Cooper, 1995) . These cascades are activated by a wide variety of stimuli including mitogens and other cytokines as well as environmental stresses. In their simplest form, MAP kinase modules consist of three distinct kinases arrayed in a linear cascade, in which the upstream kinase phosphorylates and thereby activates the downstream kinase. Such a linear cascade allows regulation and integration of signals at multiple steps along the pathway. The output of the cascade, activation of kinases of the MAP kinase family, leads to phosphorylation of a wide variety of substrate proteins. Because the activated MAP kinases can enter the nucleus (Chen et al., 1992; Dickens et al., 1997; Lenormand et al., 1993; Raingeaud et al., 1995; Seth et al., 1992) , they can directly modulate transcriptional regulation by phosphorylating transcription factors and other nuclear proteins. MAP kinase cascades, therefore, are an important mechanism for transducing signals to the nucleus where they ultimately aect the transcriptional and replication programs.
The most extensively studied MAP kinase pathway in vertebrates consists of the three kinases Raf, Mek, and Erk (each of which is actually represented by several closely-related family members, e.g. Erk1 and Erk2). The most downstream kinase in the cascade, Erk, is activated by phosphorylation of threonine and tyrosine residues in its`activation loop' by the multifunctional protein kinases of the Mek family (Canagarajah et al., 1997; Cobb and Goldsmith, 1995; Johnson et al., 1996) . Because of their function as activators of MAP kinases, Mek and its relatives are often termed MAP kinase kinases or MAPKKs. Mek is in turn activated by phosphorylation on serine residues by the Raf family of kinases (an example of a MAP kinase kinase kinase or MAPKKK).
At least three distinct MAP kinase signaling modules exist in mammalian cells, as de®ned by the family of MAPKs that is ultimately activated. The pathway leading to activation of Erks is largely responsive to mitogenic stimuli. Two other major pathways result in activation of the Stress Activated Protein Kinase (SAPK)/Jun N-terminal Kinase (JNK) family (Derijard et al., 1994; Kyriakis et al., 1994) , or the p38/ Mpk2/Hog1 kinase and its relatives (Freshney et al., 1994; Han et al., 1994; Lee et al, 1994; Rouse et al., 1994) . These pathways are activated by a wide and overlapping spectrum of stimuli that can broadly be characterized as stresses, which include tumor necrosis factor, interleukin-1, osmotic shock, heat shock, ultraviolet radiation, DNA damage, and inhibitors of protein synthesis (reviewed in Kyriakis and Avruch, 1996; Paul et al., 1997; Pelech, 1996) . The MAPKKs that activate SAPK/JNK and p38 are thought to be SEK/MKK4 (Derijard et al., 1995; Lin et al., 1995; Sanchez et al, 1994) or MKK7 (Holland et al., 1997; Moriguchi et al., 1997; Tournier et al., 1997; Wu et al., 1997; Yao et al., 1997) for SAPK/JNK and MKK3 or MKK6 for p38 (Derijard et al., 1995; Han et al., 1996; Raingeaud et al., 1996) . While it is clear that these two pathways are quite distinct from the MAPK pathway that activates Erk, it is less clear to what extent the SAPK/JNK and p38 pathways are interconnected. Because both of these pathways respond to similar upstream stimuli, yet can lead to phosphorylation of dierent downstream substrate proteins, it is important to unravel the mechanisms whereby activation of these two pathways is regulated.
In this study we have used transient transfection and in vitro reconstitution approaches to analyse the mutual regulation of several kinases involved in stress responses. We ®nd that while the SEK1/MKK4 (SEK) kinase can, as expected, activate p54 SAPKb/JNK3 (p54), it is also an extremely potent inhibitor of p54 when present at or above stoichiometric levels. Furthermore, this inhibition is remarkably speci®c: SEK cannot inhibit the p38 MAP kinase, nor can p54 be inhibited by the p38 activator XMek3/MKK6. Our data suggest that the local concentration of SEK relative to p54 in the cell has the potential to modulate the cellular response to stress by determining which MAP kinases are activated and the kinetics of their activation.
Results
We have employed a transient transfection system to study the regulation of various kinases involved in MAP kinase signaling cascades. In this system kinases are expressed at high levels in human 293-T cells as glutathione S-transferase (GST) fusions to allow the rapid and quantitative puri®cation of the GST-fused kinases. A major advantage of the GST fusion approach is that the quantities of soluble protein recovered are sucient to allow multiple experiments with normalized stocks of puri®ed proteins. This circumvents potential problems associated with immune complex kinase assays, where antibody binding can vary from experiment to experiment and can also directly aect kinase activity or interaction with other proteins. Furthermore, unlike other systems that allow puri®cation of sucient protein for solution biochemistry experiments (expression in bacteria or baculovirus-infected insect cells), 293-T cells can be manipulated to induce activation of kinase cascades.
SEK is both an activator and an inhibitor of p54
We ®rst examined what eect the level of expression of SEK1, the supposed activator of p54 SAPKb/JNK3 (p54), had on the activity of p54 puri®ed from cells cotransfected with constant amounts of plasmid expressing GST p54 and increasing amounts of plasmid encoding untagged SEK. As shown in Figure  1 , expression of low levels of SEK increased the speci®c kinase activity of GST-p54 relative to GST-p54 isolated from cells transfected with p54 alone, as expected given the proposed role of SEK as a direct activator of p54. This was the case both with and without treatment with the protein synthesis inhibitor anisomycin, which activates stress-responsive pathways, although in all cases the speci®c activity of p54 was higher when isolated from anisomycin-treated cells as expected if GST-p54 can be activated by the endogenous stress-response machinery. Surprisingly, however, higher levels of SEK expression relative to GST-p54 resulted in the inhibition of p54 speci®c kinase activity, inconsistent with a role for SEK as a simple activator of p54. The inhibition of p54 was quite strong, reducing activity to levels below those seen in cells transfected with p54 alone, and was seen both in the absence and presence of anisomycin treatment. As expected, immunoblotting of whole cell lysates with antisera recognizing SEK or GST showed comparable levels of GST-p54 in all samples and increasing amounts of SEK as the amount of SEK plasmid transfected was increased (data not shown). Similar results were seen if in¯uenza virus hemagglutinin (HA) epitope-tagged p54 was used instead of the GST-tagged version (data not shown) so inhibition of p54 cannot be ascribed to eects of the GST fusion partner. These data demonstrate that high levels of SEK expression repress the activation of p54 in vivo.
The ability of SEK to inhibit p54 activity in vivo could be either direct (through SEK-p54 interaction) or indirect (via the induction of phosphatase activities or other feedback mechanisms). In order to determine whether the inhibition of p54 was due directly to the presence of SEK, we puri®ed GST fusions of SEK and p54 from singly-transfected cells with or without anisomycin treatment to activate the SEK or p54 in vivo. We then tested the ability of increasing amounts of puri®ed SEK protein to aect the kinase activity of puri®ed p54 when the two kinases were mixed in vitro. When increasing amounts of puri®ed GST-SEK protein were added to the p54 kinase reactions, there was little eect of addition of small amounts of SEK but addition of higher amounts resulted in the strong inhibition of p54 kinase activity (Figure 2 ). Strongest inhibition was seen beginning at levels of SEK corresponding to a 1 : 1 molar ratio of SEK : p54, suggesting that the two proteins form a stoichiometric complex and that p54 in this complex is strongly inhibited. SEK was able to inhibit p54 isolated from both control cells and from anisomycin-treated cells, although the inhibition of anisomycin-activated p54 Figure 1 Dependence of p54 activity on levels of SEK in vivo. 293-T cells were transfected with a constant amount of plasmid expressing GST-p54 (4 mg) and variable amounts of plasmid expressing untagged SEK (0 ± 16 mg). Transfections were performed in duplicate and one set was treated with anisomycin for 30 min prior to lysis to activate stress response pathways. GSTp54 was puri®ed from cell lysates and equal amounts of puri®ed kinase assayed in vitro using GST-c-jun as substrate. Kinase activity is plotted as a function of ratio of SEK plasmid to p54 plasmid transfected. Open boxes, untreated cells; open diamonds, anisomycin-treated cells was less complete (approximately 80% inhibition of activated p54 versus essentially complete inhibition of p54 from untreated cells). Similar results were obtained with a catalytically inactive SEK protein (data not shown) indicating that inhibition of p54 did not depend on SEK kinase activity.
These data suggest that SEK is a potent inhibitor of p54 kinase activity when present in equimolar or greater quantities. This in vitro result parallels the eect seen in vivo in transfected cells (Figure 1) where expression of increasing amounts of SEK resulted in decreased p54 speci®c activity, suggesting that the inhibition of p54 seen in vivo was due directly to the presence of excess SEK. Somewhat surprisingly, SEK puri®ed from either untreated or anisomycin-treated cells was equally capable of inhibiting p54 activity (Figure 2) , suggesting that the activation state of SEK did not aect its inhibitory activity. Of course it is (a) (c) (b) Figure 2 Puri®ed SEK inhibits puri®ed p54 in vitro. 293-T cells were transfected separately with plasmids expressing GST-SEK or GST-54 and either treated with anisomycin to activate stress response pathways or left untreated. GST-SEK and GST-p54 fusion proteins were puri®ed from lysates and normalized. Constant amounts of GST-p54 were assayed for ability to phosphorylate GSTc-jun in vitro in the presence of varying amounts of GST-SEK. possible that only a small fraction of the SEK isolated from anisomycin-treated cells is activated; if this were the case it might be dicult to detect a decrease in inhibitory activity.
Inhibition of p54 by excess SEK in vitro was observed over a wide range of protein concentrations; in the experiments shown in Figure 2 the p54 protein was present at a concentration of 2610 77 M, and we have also observed similar inhibition when both SEK and p54 were present at 52610 79 M (data not shown). This strong inhibition even at low enzyme concentrations, coupled with the relatively weak kinase activity of p54, made it dicult to perform standard enzymological assays to calculate the mechanism of inhibition by SEK or the K i . Inhibition was unlikely to be due to a copurifying protein because Coomassie blue staining of protein preparations did not reveal any SEK-speci®c bands staining at similar intensity to GST-SEK itself (see Figure 2c ). Furthermore the inhibition was unaected by including a cocktail of phosphatase inhibitors in the kinase reaction mixes (data not shown).
We were also surprised to ®nd that SEK lacked the ability to strongly activate p54 in vitro under these conditions, even when present at substoichiometric levels (Figure 2 ), although we did reproducibly observe a slight activation of p54 by activated SEK (isolated from anisomycin-treated cells). This contrasts with what was seen in vivo, where expression of relatively low levels of SEK greatly potentiated the activation of p54 (see Figure 1) . We considered the possibility that the activation of p54 by SEK in vitro was slow, and therefore was not observed during the 10-min kinase reaction used for the experiments shown in Figure 2 . To address this possibility, puri®ed unactivated p54 (isolated from untreated cells) and activated SEK (isolated from anisomycin-treated cells) were mixed in a 4 : 1 molar ratio and preincubated in an ATP-containing reaction buer for various times before the addition of substrate and labeled ATP. As can be seen in Figure 3 , preincubation resulted in substantial activation of p54 (greater than fourfold) which was dependent on the presence of ATP in the preincubation mix and on the presence of SEK. Kinase inactive mutant SEK was unable to activate p54 under these conditions (data not shown). This demonstrates that SEK does indeed have the ability to activate p54 by phosphorylation in vitro, but that this activation is very slow.
If the preincubation and kinase assay were performed in the presence of excess unactivated SEK protein (twofold excess over p54, and eightfold over activated SEK), no activation of p54 was seen, consistent with a model in which p54 that is bound to SEK is inhibited. However, it excess SEK was added after preincubation with unlabeled ATP and activated SEK (just prior to addition of substrate and labeled ATP), partial activation of p54 was seen relative to p54 that had not been preincubated. This suggests that in the absence of excess SEK, some p54 became activated (presumably by phosphorylation) in a way that rendered it less susceptible to subsequent inhibition by SEK; this is consistent with the results shown in Figure 2 , where p54 isolated from anisomycin-treated cells and thereby activated was only partially susceptible to inhibition by SEK.
SEK inhibitory activity maps to the unique N-terminal domain
We next constructed a series of deletion mutants of SEK to determine which regions were necessary and sucient for inhibition of p54 (Figure 4a ). Two alternative initiation codons have been described for SEK (Derijard et al., 1995; Lin et al., 1995; Sanchez et al., 1994; Yashar et al., 1993) , leading to some confusion about what constitutes the bona ®de Nterminus, and alternative splicing has also been reported (Yashar et al., 1993) . The apparent molecular weight of SEK recognized in immunoblots of mouse ®broblasts and human embryonic kidney cells is most consistent with a protein initiating at the ®rst methionine, 34 residues upstream from the methionine used as the amino terminus in the`wt' SEK constructs used for most experiments in this study (data not shown). We have constructed GST-tagged and untagged versions of full-length (FL)' SEK which include this upstream ATG, but because the GST version of this`FL' SEK is only marginally soluble and therefore dicult to purify in quantity, we chose to use the shorter`wt' SEK for all in vitro studies. However in experiments similar to those shown in Figure 1 , transfection of super-stoichiometric amounts of untagged`FL' SEK strongly inhibited the activity of cotransfected HA-tagged p54 in vivo (data not shown), suggesting that the major in vivo species of SEK has similar inhibitory properties to the shorter wt' version used here.
The 104 N-terminal residues of SEK upstream of the highly conserved protein kinase catalytic domain Figure 3 Time-dependent activation of p54 by activated SEK. p54 was preincubated in kinase buer containing unlabeled ATP in the presence of 1 : 4 molar ratio of activated SEK to p54 as described in Materials and methods. At indicated times the reaction was supplemented with labeled ATP and GST-c-jun substrate and kinase reaction allowed to proceed for a further 10 min. Preincubation resulted in slow activation of p54. In the second set of reactions (middle), twofold molar excess of unactivated SEK was present throughout the preincubation and kinase reaction. The presence of excess SEK blocked p54 activation. In the third set, twofold excess of unactivated SEK was added after the preincubation and was present during the kinase reaction. p54 activated by preincubation was partially inhibited by excess SEK. Control reactions contained no p54, no activated SEK (`no SEK(+)'), or no ATP in the preincubation reaction share little homology with other MAPKKs such as MEK, MKK6, or MKK7. As shown in Figures  4a,b , deletion of the ®rst 69 residues of this Nterminal unique domain completely abolished the ability of SEK to inhibit p54. This truncated kinase was also unable to activate p54 in vitro (Figure 4b and data not shown) although the kinase domain was intact, suggesting that the N terminus is also required for ecient recognition of p54 as a substrate of SEK (or, less likely, for catalytic activity itself). A GST fusion containing an Nterminal 70-residue segment of SEK was sucient to inhibit the activity of p54 (Figures 4a,c) although the inhibition was less ecient than with full-length SEK (50% inhibition of p54 activity at a concentration of approximately 5610 77 M, while inhibition by wt SEK is essentially complete at nanomolar concentrations). Therefore while an N-terminal segment of SEK including residues 35-69 is necessary and at least partially sucient for inhibition of p54, the catalytic domain presumably increases the anity of the interaction. Consistent with this, we found that SEK proteins lacking the N-terminal 69 or 104 residues still co-immunoprecipitated with tagged p54, albeit at a lower eciency than for wt SEK (data not shown).
Regulatory relationships between SEK, MKK6, SAPK and p38
We sought to extend our observations on the regulation of p54 by SEK to other MAP kinase cascades that respond to stress. The other well characterized mammalian stress-response pathway involves the activation of p38/Mpk2/Hog1 (Freshney et al., 1994; Han et al., 1994; Lee et al., 1994; Rouse et al., 1994) , which responds to a set of stress stimuli overlapping with those that activate p54 and is particularly associated with responses to osmotic stress. p38 is thought to be activated by MEK homologs MKK3 and MKK6 (Derijard et al., 1995; Han et al., 1996; Moriguchi et al., 1996b; Raingeaud et al., 1996) .
In the course of a screen for novel MAP kinase activators (Yashar et al., 1993) we isolated a Xenopus homolog of MKK6, which we termed XMek3, from a Xenopus cDNA library. As shown in Figure 5 , the protein encoded by the full-length XMek3 cDNA is 92% identical and 94% similar to human MKK6, suggesting that its function as a p38-activating kinase would be conserved between species. Consistent with this, we have found that murine SEK and its Xenopus homolog XMek2 are indistinguishable in their ability to regulate p38 or p54 in transfected 293-T cells (MW Kieran and LI Zon unpublished observation). We therefore used XMek3 as a model p38-speci®c MAPKK to address the regulatory relationships between kinases involved in the p38 and p54 MAP kinase pathways. GST-SEK and GST-XMek3 were prepared from anisomycin-treated 293-T cells and analysed for their ability to regulate GST-p38 and GST-p54 in vitro. As shown in Figure 6 , XMek3 eciently activated both p38 (Figure 6a ) and p54 (Figure 6b) , and no inhibition of either p54 or p38 was seen when a twofold excess of XMek3 was added. Similarly, SEK was able to activate p38 quite eciently in vitro, but did not inhibit it when present in twofold excess (Figure 6a ). Because both XMek3 and SEK were capable of modulating p54 activity, we also examined whether an excess of SEK could block XMek3-induced activation of p54. We found that equimolar amounts of SEK eciently inhibited the activity of p54 even in the presence of a twofold excess of XMek3, demonstrating that the inhibitory activity of SEK is dominant over the stimulatory activity of XMek3 (data not shown).
SEK may block either the binding of XMek3 to p54 or its access to the activating phosphorylation site.
The regulatory relationships among the four kinases analysed here are represented in Figure 7 . While SEK and XMek3 each have the ability to activate either p38 or p54 in vitro, SEK is uniquely able to inhibit p54 when present in greater than stoichiometric quantities. Therefore when all four kinases are present in cells, the level of SEK protein relative to the levels of the other kinases would be predicted to strongly aect the ultimate response to stress stimuli. If SEK were present in excess of p54 it would inhibit p54, and upstream stimuli feeding into either the SEK or XMek3 pathways would therefore lead predominantly to activation of p38; in contrast, if p54 were present in excess of SEK, then stimuli feeding into the SEK or XMek3 pathways would likely result in activation of both p54 and p38.
We have modeled this type of regulation in vitro using a simple reconstituted system with three puri®ed kinases: GST-p54, GST-p38 (both isolated from untreated cells) and GST-SEK (isolated from anisomycin-treated cells and thus activated). When the p54 Figure 5 Sequence comparison of Xenopus and mammalian stress-activated MAPKKs. Murine SEK, Xenopus XMek2 and XMek3, and human Mkk6 and Mkk3 are aligned and residues identical in at least two of the sequences are highlighted. The positions of the N-terminal borders of the SEK truncation mutants described in Figure 4 are indicated above the alignment and p38 levels were held constant and increasing amounts of SEK were titrated into the reaction, we observed that at relatively low SEK levels GST-c-jun (a p54-speci®c substrate) was highly phosphorylated relative to myelin basic protein (MBP, a preferred substrate for p38), whereas at higher levels of SEK, MBP was preferentially phosphorylated (Figure 8a) . Thus as the SEK concentration in the reaction increased, the ratio of GST c-jun phosphorylation to MBP phosphorylation changed dramatically in favor of the p38 substrate MBP (Figure 8b ). This ratio was very sensitive to the amount of SEK when the concentrations of SEK and p54 were nearly equal; in our experiment a twofold dierence in the ratio of SEK to p54 caused an almost sevenfold dierence in the ratio of GST-c-jun to MBP phosphorylation (Figure 8b ). This strongly suggests that the relative levels of SEK, p54, p38, and p38 activators in vivo will be important parameters governing the response of cells to stresses.
Discussion
Our results reveal a novel regulatory relationship between a MAP kinase kinase, SEK1, and one of its supposed targets, the stress-activated MAP kinase p54 SAPKb/JNK3. While SEK can slowly activate p54 when present at substoichiometric levels, if SEK is present in molar excess it is a highly potent inhibitor of p54. Our results are most easily explained by a high anity complex between the two kinases in which p54 is catalytically inactive. This inhibitory relationship is highly speci®c, as it was not seen in three other MAPKK-MAPK pairs analysed. While previous results have suggested that complexes between MAPKKs and MAPKs might be a general feature of MAP kinase signaling modules (see , and it has long been appreciated that SEK and p54 could stably associate (Sanchez et al., 1994; Zanke et al., 1996) , inhibitory interactions have not been previously described.
A hallmark of signal transduction mechanisms is supersensitivity', or the ability of relatively small changes in upstream inputs to lead to disproportionately large changes in downstream outputs. Our data suggest a potential regulation of p54 by SEK whereby small changes in the relative levels of the two kinases could have dramatic eects on whether SAPK/JNK is activated or inhibited. Because the 1 : 1 complex of SEK and p54 is essentially completely inhibited, if Speci®city of activation and inhibition of MAPKs by MAPKKs. Puri®ed GST-p38 (a) or GST-p54 (b) was mixed with either GST-SEK or GST-XMek3 (which had been activated by anisomycin treatment) at a molar ratio of 1 : 4 or 2 : 1. Activation of p38 and p54 was monitored by in vitro kinase assay using MBP or GST-c-jun, respectively, as substrate Figure 7 Diagrammatic representation of the regulatory relationships between SEK, XMek3/MKK6, p54, and p38 based on in vitro activation and inhibition. SEK can either activate or inhibit p54 depending on the relative concentration of the two kinases. It should be noted that, in contrast to our results with Xmek3 and p54 SAPKb/JNK3, others have reported that Mkk6 cannot phosphorylate or activate JNK1 or JNK2 (Cuenda et al., 1996; Han et al., 1996; Moriguchi et al., 1996a; Raingeaud et al., 1996; Stein et al., 1996) locally SEK were in slight excess, a subsequent slight increase in p54 level or decrease in SEK level would result in the appearance of free p54 and a very sharp rise in p54 kinase activity. This presents the intriguing possibility that the levels of either p54 or of SEK might be modulated in response to extracellular signals or during development. It will be important to test the extent to which such a mechanism contributes to regulation of SAPK/JNK activity in normal cells. We have quantitated the amounts of endogenous SEK and SAPK/JNKs in 293-T and NIH3T3 cells by immunoblotting (standardized with tagged, bacterially expressed proteins), and ®nd that the two proteins are present in approximately equimolar amounts in whole cell lysates (data not shown). This is consistent with the system being poised for small changes in the concentrations of SEK and/or SAPK/JNK to result in large eects on p54 activity.
We have yet to observe conditions in which the absolute levels of SEK and SAPK dramatically change in cells, but this by no means precludes such dierences under some conditions or locally within the cell.
There are several precedents for regulation of MAP kinases by protein ± protein association. For example, it has been shown in yeast that the three kinases of the MAP kinase cascade involved in mating pheromone response (Ste11, Ste7, and Fus3/Kss1) are all found in a complex with a`docking protein' termed Ste5 (Choi et al., 1994; Marcus et al., 1994; Printen and Sprague, 1994) . Similar scaolding proteins have recently been described for mammalian MAP kinases (Schaeer et al., 1998; Whitmarsh et al., 1998) . Other studies in the yeast system have shown that Ste7 (a MAPKK) binds very tightly via its N-terminus to the MAPKs Fus3 and Kss1, reminiscent of the SEK-p54 complex described here. Although binding to Ste7 does not appear to result in inhibition of MAPK activity, there is evidence that Ste7 phosphorylates and activates Kss1 only after dissociation of the complex .
Stable complex formation also appears to be involved in the regulation of Erk by its upstream activator, Mek. Nishida and colleagues have proposed a model (Fukuda et al., 1997) in which Mek binds tightly to Erk and sequesters it in the cytoplasm in an inactive complex; upon activation of Erk the complex dissociates, allowing Erk to diuse into the nucleus to access its substrates while Mek is retained in the cytoplasm via its nuclear export signal. Upstream signals must lead to rapid dissociation of the inhibited complex, and these authors suggested that phosphorylation of Mek by Erk might trigger this dissociation. Phosphorylation of Erk has been shown to induce its dimerization and nuclear localization, suggesting another mechanism for preventing reassociation with Mek (Khokhlatchev et al., 1998) .
Several notable features are apparent upon examination of the region of SEK implicated in inhibition, including the presence of three Asn-Pro motifs. Sequences containing Asn-Pro dipeptides have been proposed to be a common feature of`docking sites' that could mediate association between MAPKs and MAPKKs . It is interesting to speculate that Asn-Pro dipeptides might also act as pseudosubstrate inhibitors, given the speci®city of MAP kinases for Ser-Pro or Thr-Pro dipeptide substrates (Clark- Lewis et al., 1991; Songyang et al., 1996) . The N-terminus of SEK is subject to alternative splicing in both mouse and Xenopus (LI Zon, unpublished data and Yashar et al., 1993) raising the possibility that the association with downstream MAP kinases could be altered in some spliced forms.
We did not ®nd any sequence similarity between the N terminus of SEK and p21 Cip1/WAF1 , which has been shown to inhibit SAPK/JNK in vitro (Shim et al., 1996) , or Jip1, a scaold protein that can inhibit SAPK/JNK in vivo (Dickens et al., 1997) . We have found that a large excess of GST-p21 is required to attain 50% inhibition of GST-p54 in vitro, whereas GST SEK inhibits maximally at near stoichiometric levels (data not shown). Therefore, under these conditions (i.e. in solution with p54 concentrations in the range of 10 77 M), SEK is a more potent inhibitor of p54 than is p21.
One potential function for the high-anity SEK-p54 complex might be to provide a delayed-action`timer' for activation of p54 by SEK. Because we propose that the activation of p54 is dependent on dissociation of the SEK-p54 complex, the rate of which would be (610) is plotted as a function of molar ratio of SEK : p54 dictated only by the intrinsic o-rate of the complex, the activation of p54 by SEK might therefore be delayed relative to other responses to stress. We have examined the kinetics of activation of p54 in response to anisomycin in 293-T cells in vivo, and ®nd that maximal activation requires at least 30 min (data not shown), consistent with the slow kinetics of activation observed in vitro (Figure 3) . Some stress stimuli have been shown to induce rapid activation of SAPK/JNK activity in vivo (within 5 min), which might be explained by other upstream activators of SAPK/ JNK such as MKK7 (Holland et al., 1997; Moriguchi et al., 1997; Tournier et al., 1997; Wu et al., 1997; Yao et al., 1997) or other MKKs. Therefore the relative level of SEK has the potential to control the kinetics as well as the extent of SAPK/JNK activation.
Careful analysis of the association and regulatory relationships between puri®ed MAP kinases (and their many alternately spliced forms) will undoubtedly reveal further complexities in their regulatory interactions. Evidence is beginning to accumulate suggesting that p38 and p54 activities can be dierentially regulated in dierent cell types (Mendelson et al., 1996; Zanke et al., 1996) . Although data from murine cell lines in which SEK function is eliminated by homologous recombination suggest that SEK is relatively speci®c for activating the SAPK/JNK kinases in vivo (Ganiatsas et al., 1998; Nishina et al., 1997; Yang et al., 1997) , signi®cant cross-talk between the SAPK/ JNK and p38 pathways in response to some stimuli has been shown (Ganiatsas et al., 1998) . Our results suggest that it will be important to analyse differences in the relative concentrations of various components of MAP kinase cascades in dierent cell types and changes in these relative concentrations in response to stimuli.
Materials and methods
Cell culture and protein production 293-T cells were cultured in Dulbecco's Modi®ed Eagle Medium (DME) supplemented with 10% fetal calf serum plus antibiotics. Cells were transfected by the calcium phosphate method as described (Tanaka et al., 1995) . Routinely 2 ± 4 mg of pEBG-derived plasmids expressing GST-fused kinases (Sanchez et al., 1994) were transfected per 10-cm plate. For some experiments, anisomycin (10 mg/ ml stock in DMSO) was added to a ®nal concentration of 40 mg/ml for 30 min prior to harvesting the cells. Cells were lysed 2 days post-transfection with 1 ml KLB buer (25 mM Tris pH 7.4, 150 mM NaCl, 5 mM Na 2 EDTA, 10 mM bglycerophosphate, 10 mM sodium pyrophosphate, 1 mM Na 3 VO 4 , 1% Triton X-100, 10% glycerol, plus protease inhibitors) on ice for 30 min. Cells were scraped into microfuge tubes and centrifuged for 10 min in a microfuge to remove insoluble debris.
GST fusion proteins were puri®ed by incubating cell lysates with glutathione-Sepharose (Pharmacia) with rotation at 48C for 30 min, then washing repeatedly with KLB buer. Proteins were eluted batchwise with 50 mM HEPES pH 7.5, 20 mM reduced glutathione, 10% glycerol (two elutions, 10 min each). Routinely over 50 mg of fusion protein could be puri®ed from one 10-cm dish of 293-T cells. Samples were diluted to equal concentrations (usually approximately 10 76 M) and stored at 7708C in elution buer. Proteins were roughly normalized by Coomassie blue staining and absolute protein concentration was tested by immunoblotting with anti-GST antibodies in parallel with serial dilutions of bacterially-produced GST fusion protein of known concentration.
Kinase assays
Kinase activity was assayed in 20 ml reaction volumes routinely containing 2 ± 4 ml GST-p54 (2 ± 4 pmol, ®nal concentration *1 ± 2610 77 M) in buer containing 50 mM HEPES pH 7.5, 10 mM MgCl 2 , 100 mM ATP, 10 mCi [g-32 P] ATP, and 0.1 mg/ml GST-c-jun protein substrate. For p38 kinase assays identical conditions were used except the substrate was 0.2 mg/ml myelin basic protein (MBP). Reactions were incubated at 308C for 10 min or as noted and were terminated by the addition of 1/4 volume 56Laemmli sample buer. Because puri®ed proteins comprised a signi®cant proportion of the total reaction volume, kinase reactions also contained between 8 ± 12 mM glutathione and 4 ± 6% glycerol from the elution buer. Within any one experiment the amount of glutathione and glycerol in all reactions was kept constant. All kinase experiments were repeated at least once with essentially identical results.
Reaction products were separated by SDS ± PAGE, gels were ®xed, stained, dried, and exposed to X-ray ®lm. For quantitation substrate bands were excised and Cerenkov counts determined in a scintillation counter. For experiments in which the eect of added SEK (or XMek3) was tested, the amount of substrate phosphorylation seen in parallel reactions with SEK (or XMek3) alone in the absence of p54 (or p38) was subtracted and the remaining activity attributable to p54 (or p38) is shown.
For the time course of activation experiment (Figure 3 ), three sets of reactions were set up containing 4 pmol p54 from untreated cells and 1 pmol SEK from anisomycintreated cells (`activated SEK'), in a reaction buer containing 50 mM HEPES pH 7.5, 10 mM MgCl 2 , 100 mM ATP, 100 mg/ ml acetylated BSA but lacking substrate or labeled ATP; one set of reactions was supplemented with 8 pmol SEK from untreated cells (`unactivated SEK'). Tubes were incubated for 0, 5, 10, 20, or 40 min at 308C, then a reaction mix containing substrate and labeled ATP was added (and 8 pmol unactivated SEK, to one of the sets of reactions lacking unactivated SEK in the preincubation period). The reaction was allowed to proceed a further 10 min at 308C before stopping with 56 sample buer. For each set of reactions, controls included reactions with no p54, with no ATP in the preincubation reaction, and with no activated SEK (all preincubated 40 min).
For the reactions shown in Figure 8 , all tubes contained 4 pmol unactivated p54 and 0.2 pmol unactivated p38. Tubes were preincubated for 30 min at 308C as above in buer containing ATP and BSA but lacking substrate or labeled ATP. Reactions were then supplemented with GST-c-jun and MBP substrates and 32 P-labeled ATP and incubated for a further 10 min at 308C.
Isolation of XMek3
Full length XMek3 cDNA was cloned from a stage 45 Xenopus cDNA library constructed in the lZAPII phagemid vector (Stratagene). 7.5610 5 phage were screened by standard plaque hybridization protocols using a 32 P-labeled DNA probe corresponding the 138 nucleotide PCR fragment of XMek2 previously reported (Yashar et al., 1993) . Eight phage clones were isolated and the full-length cDNA was sequenced by the dideoxy chain termination method using Sequenase (US Biochemical). The alignment in Figure 6 was prepared using the Pileup program of the GCG package and formatted using the Boxshade program.
DNA constructions
Mammalian vectors expressing GST fusions of rat p54 and murine SEK1 have been described (Sanchez et al., 1994) . Similar constructs expressing GST-XMek3 (the Xenopus homolog of MKK6) and murine p38 were constructed in the EBG vector. Untagged SEK was cloned into the pEBB vector, which is identical to pEBG except for the absence of GST fusion partner sequences (Tanaka et al., 1995) . The GST-SEK and untagged SEK constructs used for most of these studies lack the 34 N-terminal residues upstream of the second in-frame methionine residue (Lin et al., 1995; Sanchez et al., 1994) . Constructs containing the N-terminal sequences between the ®rst and second in-frame methionines were relatively insoluble as GST fusions.
Truncation mutants of SEK were constructed by polymerase chain reaction using 5' primers with BamHI sites and 3' primers with NotI sites. If the ®rst in-frame methionine (discussed above) is considered residue 1, the del2 mutant contains residues 70 ± end, the del3 mutant contains residues 97 ± end, and the Nter mutant contains residues 35 ± 98. Fragments were ampli®ed from the full-length murine SEK cDNA by standard protocols using Pfu DNA polymerase (Stratagene) and inserted into pEBG vector cleaved with BamHI and NotI. Multiple clones of each mutant were analysed and had identical properties.
